Boston Trust Walden’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-653,969
| Closed | -$52.2M | – | 391 |
|
|
2021
Q1 | $52.2M | Sell |
653,969
-13,580
| -2% | -$1.06M | 0.51% | 63 |
|
|
2020
Q4 | $52.6M | Buy |
667,549
+90,704
| +16% | +$5.32M | 0.56% | 50 |
|
|
2020
Q3 | $25.3M | Buy |
576,845
+24,391
| +4% | +$1.2M | 0.32% | 107 |
|
|
2020
Q2 | $24.4M | Buy |
552,454
+38,910
| +8% | +$1.45M | 0.33% | 94 |
|
|
2020
Q1 | $18.4M | Buy |
513,544
+192,333
| +60% | +$10.9M | 0.29% | 110 |
|
|
2019
Q4 | $22.8M | Buy |
321,211
+90,902
| +39% | +$6.59M | 0.27% | 117 |
|
|
2019
Q3 | $17.2M | Buy |
230,309
+90,202
| +64% | +$7.65M | 0.22% | 144 |
|
|
2019
Q2 | $11.3M | Buy |
+140,107
| New | +$9.85M | 0.15% | 183 |
|
|
2016
Q1 | – | Sell |
-141,065
| Closed | -$8.77M | – | 350 |
|
|
2015
Q4 | $8.77M | Sell |
141,065
-73,710
| -34% | -$4.5M | 0.16% | 182 |
|
|
2015
Q3 | $12.2M | Sell |
214,775
-6,163
| -3% | -$326K | 0.2% | 177 |
|
|
2015
Q2 | $11.9M | Sell |
220,938
-121,222
| -35% | -$5.9M | 0.18% | 179 |
|
|
2015
Q1 | $16.3M | Sell |
342,160
-99,941
| -23% | -$4.42M | 0.24% | 155 |
|
|
2014
Q4 | $19.1M | Sell |
442,101
-29,665
| -6% | -$1.21M | 0.28% | 139 |
|
|
2014
Q3 | $16.2M | Sell |
471,766
-21,937
| -4% | -$775K | 0.25% | 154 |
|
|
2014
Q2 | $18.1M | Sell |
493,703
-22,585
| -4% | -$766K | 0.26% | 150 |
|
|
2014
Q1 | $17.4M | Sell |
516,288
-15,965
| -3% | -$527K | 0.26% | 148 |
|
|
2013
Q4 | $18M | Sell |
532,253
-543,184
| -51% | -$18.8M | 0.26% | 148 |
|
|
2013
Q3 | $34.3M | Sell |
1,075,437
-25,260
| -2% | -$672K | 0.52% | 85 |
|
|
2013
Q2 | $24.9M | Buy |
+1,100,697
| New | +$23.8M | 0.4% | 121 |
|
Boston Trust Walden's CMD Position: Q2 2021 in Review
Boston Trust Walden sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 653,969 shares — an estimated $52.2M sold.
Boston Trust Walden first reported a position in CMD in Q2 2013 and held it in 19 quarters. The position peaked at $52.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Boston Trust Walden reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Boston Trust Walden sold 653,969 Cantel Medical Corporation shares in Q2 2021, an estimated $52.2M.
- Boston Trust Walden first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 19 quarters.
- Boston Trust Walden's Cantel Medical Corporation position peaked at $52.6M in Q4 2020.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Boston Trust Walden's 13F filing for Q2 2021, filed 22 Jul 2021.